Clincosm LogoSign in Get a demo

Influence of Different Ankle Positions on Nerve Conduction Parameters of Deep Peroneal Nerve

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT05635721
Collaborator
(none)
31
Enrollment
1
Location
1.7
Actual Duration (Months)
18.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

BACKGROUND:

The deep peroneal nerve arises as a branch of the common peroneal nerve which courses around the neck of the fibula. The motor component of deep peroneal nerve is responsible for innervating the anterior compartment of the lower leg which includes the tibialis anterior, extensor hallucis longus, extensor digitorum longus, and peroneus tertius muscles.

Nerve conduction velocity shortly known as "NCV" tests are used determine the speed of the electrical signals moving along a specific peripheral nerve .This will be helpful in localizing the site of entrapment of peripheral nerves and useful for assessing both recovery and prognosis of any injury to peripheral nervesthere are numerous aspects that could influence nerve conduction study.

Although changes in joint position have been reported in several studies to affect nerve conduction velocity of peripheral nerves. the effect of changing ankle joint position on deep peroneal NCV has not been repor Purpose

This study will investigate the effect of different ankle positions on:

  1. Deep peroneal nerve distal motor latency across ankle joint.

  2. Deep peroneal nerve sensory onset latency across ankle joint

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    31healthy subjects of both genders with age ranging from 20to 40years old were examined for motor distal latency and sensory onset latency at three different ankle positions :neutral,20degrees dorsiflexion and 40degrees plantar flexion

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    31 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Influence of Different Ankle Positions on Nerve Conduction Parameters of Deep Peroneal Nerve
    Actual Study Start Date :
    Dec 5, 2022
    Actual Primary Completion Date :
    Jan 3, 2023
    Actual Study Completion Date :
    Jan 26, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Deep peroneal nerve motor distal latency [30 minutes for each participant]

      Motor distal latency: It is the time between the distal stimulus and the onset of compound muscle action potential(CMAP)at recording muscles

    2. Deep peroneal nerve sensory onset latency [30 minutes for each participant]

      : It is the time taken from the stimulus artifact to the initial negative deflection of the sensory nerve action potential (SNAP)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria:

    • Healthy subjects.

    • Age ranges from 20 to 40 years because longer latencies and slower nerve conduction velocity are seen significantly with increasing age.

    • All participants will be selected with body mass index (BMI) between 18.5 and 24.9kg/cm2 .

    Exclusion criteria:

    • Elderly subjects.

    • Pregnant women.

    • Subjects with history of or risk factors for peripheral nerve lesions.

    • Obese subjects.

    • Subjects with any foot deformity.

    • History of lower limb fractures.

    • History of surgery to lower limbs

    • Diabetic patients.

    • Patients with cardiovascular disorders.

    • Hypertensive patients.

    • Women wearing high heeled shoes.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mahmoud Salah Aga Egypt 055555

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: Mahmoud Salah, Faculty of physical therapy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mahmoud Salah Abd-Elfattah, Demonstrator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05635721
    Other Study ID Numbers:
    • P.T.REC/012/004076
    First Posted:
    Dec 2, 2022
    Last Update Posted:
    Jan 30, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jan 30, 2023